or Try an Advanced Search...

    Technical Analysis for ENLV - Enlivex Therapeutics Ltd.

    Grade Last Price % Change Price Change
    F 1.36 0.75% 0.01
    ENLV closed up 0.75 percent on Friday, May 31, 2024, on 4 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ENLV trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    Oversold Stochastic Weakness 0.75%
    Death Cross Bearish 3.82%
    Narrow Range Bar Range Contraction 3.82%
    Stochastic Reached Oversold Weakness 3.82%
    Gapped Down Weakness 3.82%
    Oversold Stochastic Weakness 3.82%
    20 DMA Resistance Bearish -1.45%
    Lower Bollinger Band Walk Weakness -1.45%
    Older End-of-Day Signals for ENLV ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout 1 day ago
    Down 3% 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ENLV Chart by TradingView
    Basic chart:

    Profile

    Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions

    Is ENLV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 29 Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
    May 28 Enlivex Therapeutics announces up to $15M registered direct offering
    May 28 Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
    May 21 We're Keeping An Eye On Enlivex Therapeutics' (NASDAQ:ENLV) Cash Burn Rate
    Apr 29 Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Apr 29 Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
    Apr 22 Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis
    Apr 16 Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
    Apr 15 Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why
    Apr 11 Nasdaq Jumps 250 Points; Crude Oil Down 1%
    See more ENLV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.59
    52 Week Low 1.15
    Average Volume 197,339
    200-Day Moving Average 2.29
    50-Day Moving Average 2.16
    20-Day Moving Average 1.45
    10-Day Moving Average 1.39
    Average True Range 0.14
    RSI (14) 35.06
    ADX 24.53
    +DI 18.55
    -DI 24.15
    Chandelier Exit (Long, 3 ATRs) 1.34
    Chandelier Exit (Short, 3 ATRs) 1.72
    Upper Bollinger Bands 1.62
    Lower Bollinger Band 1.28
    Percent B (%b) 0.23
    BandWidth 22.81
    MACD Line -0.18
    MACD Signal Line -0.22
    MACD Histogram 0.0424
    Fundamentals Value
    Market Cap 25.29 Million
    Num Shares 18.6 Million
    EPS -1.47
    Price-to-Earnings (P/E) Ratio -0.93
    Price-to-Sales 0.00
    Price-to-Book 1.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.44
    Resistance 3 (R3) 1.43 1.39 1.42
    Resistance 2 (R2) 1.39 1.37 1.40 1.42
    Resistance 1 (R1) 1.38 1.36 1.39 1.39 1.42
    Pivot Point 1.34 1.34 1.35 1.35 1.34
    Support 1 (S1) 1.33 1.32 1.33 1.33 1.30
    Support 2 (S2) 1.29 1.31 1.30 1.30
    Support 3 (S3) 1.27 1.29 1.30
    Support 4 (S4) 1.28